These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35524837)

  • 1. Promising role of polymeric nanoparticles in the treatment of rheumatoid arthritis.
    Siddique R; Mehmood MH; Haris M; Saleem A; Chaudhry Z
    Inflammopharmacology; 2022 Aug; 30(4):1207-1218. PubMed ID: 35524837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano - Based Therapeutic Strategies in Management of Rheumatoid Arthritis.
    Nautiyal G; Sharma SK; Kaushik D; Pandey P
    Recent Pat Nanotechnol; 2024; 18(4):433-456. PubMed ID: 37904559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Generation Smart Drug Delivery Systems for Rheumatoid Arthritis.
    Singh R; Jadhav K; Vaghasiya K; Ray E; Shukla R; Verma RK
    Curr Pharm Des; 2023; 29(13):984-1001. PubMed ID: 37038685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine is more than a supporting role in rheumatoid arthritis therapy.
    Han Y; Huang S
    J Control Release; 2023 Apr; 356():142-161. PubMed ID: 36863691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery targets and systems for targeted treatment of rheumatoid arthritis.
    Feng X; Chen Y
    J Drug Target; 2018 Dec; 26(10):845-857. PubMed ID: 29376442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancement in nanotechnology for treatment of rheumatoid arthritis: scope and potential applications.
    Rani R; Raina N; Sharma A; Kumar P; Tulli HS; Gupta M
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2287-2310. PubMed ID: 37166463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Delivery System Approaches for Rheumatoid Arthritis Treatment: A Review.
    Garhwal A; Kendya P; Soni S; Kori S; Soni V; Kashaw SK
    Mini Rev Med Chem; 2024; 24(7):704-720. PubMed ID: 37711105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate-targeted nanoparticles for rheumatoid arthritis therapy.
    Nogueira E; Gomes AC; Preto A; Cavaco-Paulo A
    Nanomedicine; 2016 May; 12(4):1113-1126. PubMed ID: 26733257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of siRNA using folate receptor-targeted pH-sensitive polymeric nanoparticles for rheumatoid arthritis therapy.
    Sun X; Dong S; Li X; Yu K; Sun F; Lee RJ; Li Y; Teng L
    Nanomedicine; 2019 Aug; 20():102017. PubMed ID: 31128293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAIL-expressing cell membrane nanovesicles as an anti-inflammatory platform for rheumatoid arthritis therapy.
    Shi Y; Xie F; Rao P; Qian H; Chen R; Chen H; Li D; Mu D; Zhang L; Lv P; Shi G; Zheng L; Liu G
    J Control Release; 2020 Apr; 320():304-313. PubMed ID: 32004586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine for the Treatment of Rheumatoid Arthritis.
    Jeong M; Park JH
    Mol Pharm; 2021 Feb; 18(2):539-549. PubMed ID: 32502346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimuli-responsive polymeric nanomaterials for rheumatoid arthritis therapy.
    Xie Y; Tuguntaev RG; Mao C; Chen H; Tao Y; Wang S; Yang B; Guo W
    Biophys Rep; 2020 Oct; 6(5):193-210. PubMed ID: 37288306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-Delivery of Prednisolone and Curcumin in Human Serum Albumin Nanoparticles for Effective Treatment of Rheumatoid Arthritis.
    Yan F; Li H; Zhong Z; Zhou M; Lin Y; Tang C; Li C
    Int J Nanomedicine; 2019; 14():9113-9125. PubMed ID: 31819422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in therapeutic strategies and biomimetic nanomedicines for rheumatoid arthritis treatment.
    Li C; Zheng X; Hu M; Jia M; Jin R; Nie Y
    Expert Opin Drug Deliv; 2022 Aug; 19(8):883-898. PubMed ID: 35760767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent advances in nanocarrier-based drug delivery systems in treatment of rheumatoid arthritis].
    Liang X; Li YL; Bai HT; Zhang QY; Xiao Z; Sun X; Wen WL; Zhang WY; Yang J; Wang R
    Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):4874-4883. PubMed ID: 37802829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent approaches for targeted drug delivery in rheumatoid arthritis diagnosis and treatment.
    Pirmardvand Chegini S; Varshosaz J; Taymouri S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):502-514. PubMed ID: 29661045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimuli-responsive Drug Delivery Systems as an Emerging Platform for Treatment of Rheumatoid Arthritis.
    Xu XL; Lu KJ; Yao XQ; Ying XY; Du YZ
    Curr Pharm Des; 2019; 25(2):155-165. PubMed ID: 30907308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric Aggregate-Embodied Hybrid Nitric-Oxide-Scavenging and Sequential Drug-Releasing Hydrogel for Combinatorial Treatment of Rheumatoid Arthritis.
    Kim T; Suh J; Kim WJ
    Adv Mater; 2021 Aug; 33(34):e2008793. PubMed ID: 34235789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and challenges.
    Ren S; Xu Y; Dong X; Mu Q; Chen X; Yu Y; Su G
    J Nanobiotechnology; 2024 Jul; 22(1):431. PubMed ID: 39034407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted drug-delivery systems in the treatment of rheumatoid arthritis: recent advancement and clinical status.
    Gorantla S; Singhvi G; Rapalli VK; Waghule T; Dubey SK; Saha RN
    Ther Deliv; 2020 Apr; 11(4):269-284. PubMed ID: 32434463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.